KR20220158760A - 사이클로필린 저해제 및 그 용도 - Google Patents

사이클로필린 저해제 및 그 용도 Download PDF

Info

Publication number
KR20220158760A
KR20220158760A KR1020227036439A KR20227036439A KR20220158760A KR 20220158760 A KR20220158760 A KR 20220158760A KR 1020227036439 A KR1020227036439 A KR 1020227036439A KR 20227036439 A KR20227036439 A KR 20227036439A KR 20220158760 A KR20220158760 A KR 20220158760A
Authority
KR
South Korea
Prior art keywords
compound
organ
alkyl
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227036439A
Other languages
English (en)
Korean (ko)
Inventor
칭-퐁 막
한스 플리리
파슈 마
마이클 필
Original Assignee
파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드 filed Critical 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드
Publication of KR20220158760A publication Critical patent/KR20220158760A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analytical Chemistry (AREA)
KR1020227036439A 2020-03-26 2021-03-25 사이클로필린 저해제 및 그 용도 Pending KR20220158760A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/081295 2020-03-26
CN2020081295 2020-03-26
CN2021078391 2021-03-01
CNPCT/CN2021/078391 2021-03-01
PCT/CN2021/083013 WO2021190601A1 (en) 2020-03-26 2021-03-25 Cyclophilin inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
KR20220158760A true KR20220158760A (ko) 2022-12-01

Family

ID=77891510

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020227036439A Pending KR20220158760A (ko) 2020-03-26 2021-03-25 사이클로필린 저해제 및 그 용도
KR1020227036440A Pending KR20220158761A (ko) 2020-03-26 2021-03-25 사이클로스포린 유도체의 제조

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020227036440A Pending KR20220158761A (ko) 2020-03-26 2021-03-25 사이클로스포린 유도체의 제조

Country Status (13)

Country Link
US (3) US12673976B2 (cg-RX-API-DMAC10.html)
EP (2) EP4126905B1 (cg-RX-API-DMAC10.html)
JP (2) JP7761578B2 (cg-RX-API-DMAC10.html)
KR (2) KR20220158760A (cg-RX-API-DMAC10.html)
CN (2) CN115335389A (cg-RX-API-DMAC10.html)
AU (1) AU2021240762A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022018929A2 (cg-RX-API-DMAC10.html)
CA (2) CA3172535A1 (cg-RX-API-DMAC10.html)
ES (1) ES3074820T3 (cg-RX-API-DMAC10.html)
IL (1) IL296586B2 (cg-RX-API-DMAC10.html)
MX (1) MX2022011697A (cg-RX-API-DMAC10.html)
TW (1) TWI917366B (cg-RX-API-DMAC10.html)
WO (2) WO2021190601A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111449050A (zh) * 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
CN116870135A (zh) 2019-10-12 2023-10-13 睿诺医疗科技(上海)有限公司 肾毒素诱发的肾损伤的治疗和预防
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
GB202207348D0 (en) * 2022-05-19 2022-07-06 Cypralis Ltd Macrocyclic compounds and uses thereof
TW202438040A (zh) * 2023-03-03 2024-10-01 大陸商睿諾醫療科技(上海)有限公司 劑誘導的肝臟病症或疾病的治療和預防
WO2024245384A1 (en) * 2023-06-02 2024-12-05 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof
WO2026119135A1 (en) * 2024-12-03 2026-06-11 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
DE69832984T2 (de) * 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
ATE254630T1 (de) 1998-06-12 2003-12-15 Chem Ag C Cyclosporine
US6809077B2 (en) 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
DK1436322T3 (da) 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
CA2518265A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
JP2007532507A (ja) * 2004-04-08 2007-11-15 ノバルティス アクチエンゲゼルシャフト 脳虚血ならびに脳および脊髄傷害の処置のためのサイクロスポリンの使用
PT1802650E (pt) * 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
CN101068829B (zh) * 2004-10-01 2012-05-30 西尼克斯公司 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物
CA2652662C (en) * 2006-05-19 2015-11-03 Scynexis, Inc. Methods for the treatment and prevention of ocular disorders
WO2008143996A1 (en) * 2007-05-18 2008-11-27 Scynexis, Inc. New chemical processes
MX2011001152A (es) 2008-07-30 2011-06-09 Isotechnika Pharma Inc Moleculas de analogo de ciclosporina no-inmunesupresoras.
RU2492181C2 (ru) 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CA2785978A1 (en) * 2009-12-30 2011-07-07 Scynexis, Inc. Cyclosporine analogues
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
DE102011111991A1 (de) 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
US20140213508A1 (en) 2012-10-19 2014-07-31 Scynexis, Inc. Antiviral macrocycles
GB201222455D0 (en) 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
GB201414806D0 (en) 2014-08-20 2014-10-01 Ucl Business Plc Cyclosporin conjugates
CN108025039B (zh) 2015-06-30 2022-07-29 西普拉里斯有限公司 新颖的大环化合物
CN106902347A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 亲环孢素抑制剂的用途
CN106902346A (zh) 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 药物组合物及其制药用途
AU2017267560B2 (en) * 2016-05-17 2022-03-24 S&T Global Inc. Novel cyclosporin derivatives and uses thereof
GB201711749D0 (en) * 2017-07-21 2017-09-06 Cypralis Ltd Cyclosporin analogues and uses thereof
WO2020037530A1 (en) 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine
CN111449050A (zh) 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
CN116870135A (zh) 2019-10-12 2023-10-13 睿诺医疗科技(上海)有限公司 肾毒素诱发的肾损伤的治疗和预防
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries

Also Published As

Publication number Publication date
US20240352074A1 (en) 2024-10-24
AU2021240762A1 (en) 2022-10-06
EP4126905C0 (en) 2026-05-13
TW202144379A (zh) 2021-12-01
MX2022011697A (es) 2022-10-07
KR20220158761A (ko) 2022-12-01
CA3172601A1 (en) 2021-09-30
IL296586B1 (en) 2026-04-01
EP4126904A1 (en) 2023-02-08
US20230174583A1 (en) 2023-06-08
ES3074820T3 (es) 2026-07-23
US12522634B2 (en) 2026-01-13
CN115298199A (zh) 2022-11-04
JP7761578B2 (ja) 2025-10-28
EP4126905B1 (en) 2026-05-13
US12673976B2 (en) 2026-07-07
TWI917366B (zh) 2026-03-11
EP4126905A1 (en) 2023-02-08
WO2021190604A1 (en) 2021-09-30
US20230110497A1 (en) 2023-04-13
JP2023518776A (ja) 2023-05-08
EP4126905A4 (en) 2024-05-29
IL296586A (en) 2022-11-01
IL296586B2 (en) 2026-08-01
JP2023518777A (ja) 2023-05-08
CA3172535A1 (en) 2021-09-30
WO2021190601A1 (en) 2021-09-30
EP4126904A4 (en) 2024-05-29
JP7776435B2 (ja) 2025-11-26
BR112022018929A2 (pt) 2022-12-06
CN115335389A (zh) 2022-11-11
US12060440B2 (en) 2024-08-13

Similar Documents

Publication Publication Date Title
JP7776435B2 (ja) シクロフィリン阻害剤およびその使用
KR20220158759A (ko) 사이클로필린 저해제 및 그 용도
JP2016512821A (ja) ヘモグロビンの修飾のための組成物及び方法
US20020142995A1 (en) Ammonium salts of hemoglobin allosteric effectors, and uses thereof
JP7839090B2 (ja) ネフロトキシン誘発性腎障害の処置及び予防
US20220072093A1 (en) Cyclosporin analogues and uses thereof
EP3860601A1 (en) Compositions for reducing serum uric acid
WO2001013933A9 (en) Agents for the enhanced oxygen delivery in mammals
KR20210148078A (ko) 조직 관류 증가에 사용하기 위한 이노시톨 포스페이트 화합물
AU2017265037B2 (en) Compounds for the treatment of ischemia-reperfusion-related diseases
CA2266533C (en) Pharmaceutical compositions comprising s-alkylisothiouronium derivatives
EA051978B1 (ru) Ингибиторы циклофилина и их применение
CN102228692A (zh) 钙通道阻断剂在制备拮抗水母毒素心脏毒性药物中的应用
KR101213600B1 (ko) 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 신기능 치료제 조성물
KR20080061431A (ko) 에이디피-라이보실 사이클레이즈 억제제를 이용한 고혈압 및 당뇨병성 신증의 치료제
EP1210944A1 (en) Blood plasma replacement solution
RU2773740C2 (ru) Способ снижения токсических и инфекционных осложнений при лечении больных с множественной миеломой
WO2025141294A1 (en) Novel hydrogen sulfide releasing compounds
KR0156985B1 (ko) 신규 2-클로로-3-치환아미노-1,4-나프탈렌디온 유도체
KR20050039700A (ko) 이식거부 치료용 화합물 및 치료 방법
RU2330660C2 (ru) ПРИМЕНЕНИЕ ИМИДАЗО[4,5-b]ИНДОЛ-2-ТИОНА ДЛЯ ЗАЩИТЫ ОТ ВОЗДЕЙСТВИЯ ГЕМИЧЕСКОЙ ГИПОКСИИ
KR20170110520A (ko) mTOR 억제제 및 N-아세틸시스테인을 포함하는 간섬유화 억제용 조성물
JP2005139092A (ja) 腎機能障害予防・治療用細胞製剤とその製造方法、腎機能障害の予防・治療方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902